Pain treatment biotech Egalet files for a $69 million IPO

By
A A A

Egalet, which is developing abuse-deterrent oral products for the treatment of pain, filed on Wednesday with the SEC to raise up to $69 million in an initial public offering. The Malvern, PA-based company, which was founded in 1995, plans to list on the NASDAQ under the symbol EGLT. Egalet initially filed confidentially on September 17, 2013. Stifel and JMP Securities are the joint bookrunners on the deal. No pricing terms were disclosed.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks:

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

Most Active by Volume

95,888,536
  • $3.935 ▲ 3.01%
49,653,838
  • $7.44 ▼ 4.12%
46,985,694
    $23 unch
41,737,554
  • $30.78 ▼ 5.38%
33,972,572
  • $95.9901 ▼ 2.20%
33,233,443
  • $15.34 ▼ 1.54%
29,126,343
  • $45.08 ▼ 2.63%
26,183,660
  • $95.373 ▼ 1.66%
As of 7/31/2014, 12:50 PM